Viewing:
All Categories
- Filter
- therapeutic tissue
- disease model
- safety testing
- liver tissue
- kidney tissue
- oncology
- bone tissue
- tissue engineering
POSTERS
June 2019
April 2019
April 2018
Modeling NAFLD using 3D bioprinted human liver tissue
EASL The International Liver Congress™ April 2018
March 2018
January 2018
Modeling NAFLD using 3D bioprinted human liver tissue
NASH-TAG Conference October 2017
October 2017
Modeling NAFLD using 3D bioprinted human liver tissue
AASLD The Liver Meeting® June 2017
3D bioprinted human liver tissue for modeling progressive liver disease
World Preclinical Congress March 2017
Utilization of the ExVive human liver tissue model to assess drug-induced liver injury across a diverse set of chemical classes
Society of Toxicology Annual Meeting March 2017
Temporal characterization of a 3D bioprinted model may provide new insight into events underlying fibrotic liver injury
Society of Toxicology Annual Meeting March 2017
Utilization of the ExVive human kidney tissue model of the proximal tubule to assess nephrotoxicity across a diverse set of chemical classes
Society of Toxicology Annual Meeting September 2016
A 3D bioprinted model of the renal proximal tubule for evaluation of drug-induced nephrotoxicity
European Societies of Toxicology September 2016
Bioprinted human tissues for toxicology and disease modeling
European Societies of Toxicology June 2016
Modeling drug-induced hepatic fibrosis in vitro using three-dimensional liver tissue constructs
World Preclinical Congress June 2016
Bioprinted human tissues for toxicology and disease modeling
World Preclinical Congress March 2016
Modeling drug-induced hepatic fibrosis in vitro using three-dimensional liver tissue constructs
Society of Toxicology Annual Meeting March 2016
Utilization of ExVive™ human liver tissues for the evaluation of valproic acid-induced liver injury
Society of Toxicology Annual Meeting` March 2016
Inflammatory response of Kupffer cells in 3D bioprinted human liver tissues
Society of Toxicology Annual Meeting March 2016
Monocrotaline toxicity in 3D-bioprinted human liver tissue
Society of Toxicology Annual Meeting March 2016
March 2015
Functional characterization of three-dimensional (3D) human liver tissues generated by an automated bioprinting platform
American Society of Experimental Biology March 2015
Design and characterization of a multicellular, three-dimensional (3D) tissue model of the human kidney proximal tubule
American Society of Experimental Biology October 2014
Three-dimensional (3D) bone tissues derived from stem cells as a novel model for mineralization
Stem Cell Meeting on the Mesa December 2013
December 2013
Bioprinted three dimensional human liver contructs provide a model for interrogating liver biology
American Society of Biology April 2013
A novel in vitro three-dimensional bioprinted liver tissue system for drug development
American Society of Experimental BiologyWEBINARS
September 2017
3D bioprinted therapeutic liver tissue
Ben Shepherd, Director Therapeutics, Organovo June 2017
Modeling NAFLD and TGF beta-induced fibrosis in ExVive™ human liver tissue
Jeff Irelan, Director Scientific Applications, Organovo | Alice Chen, Director Tissue Applications, Organovo November 2016
Monocrotaline toxicity in ExVive 3D bioprinted human liver tissue
Umesh Hanumegowda, Scientific Director, ViiV Healthcare September 2016
A 3D bioprinted model of the renal proximal tubulointerstitial interface for evaluation of drug-induced toxicity
Shelby M. King, Senior Research Scientist, Organovo July 2016
Modeling compound-induced fibrogenesis in vitro using 3D bioprinted human liver tissues
Leah Norona, UNC Chapel Hill June 2016
Use of bioprinted 3D human tissues for the assessment of drug toxicity
Sharon Presnell, Chief Scientific Officer, OrganovoPEER-REVIEWED PUBLICATIONS
January 2019
Modeling tumor phenotypes in vitro with three-dimensional bioprinting
Cell Reports. 26(3):608-623.e6 | doi: 10.1016/j.celrep.2018.12.090 January 2019
Bioprinted liver provides early insight into the role of Kupffer cells in TGF-β1 and methotrexate-induced fibrogenesis
PLoS One. e0208958 | doi: 10.1371/journal.pone.0208958 December 2018
Optimizing drug discovery by investigative toxicology: Current and future trends
Alternatives to Animal Experimentation | doi: 10.14573/altex.1808181 June 2018
Tissue engineering by self-assembly and bio-printing of living cells
Biofabrication. 2(2):022001 | doi: 10.1088/1758-5082/2/2/022001 April 2018
Bioprinted 3D primary human intestinal tissues model aspects of native physiology and ADME/Tox functions
iScience. 2:156-167 | doi: 10.1016/j.isci.2018.03.015 April 2017
3D bioengineered tissues: From advancements in in vitro safety to new horizons in disease modeling
Clinical Pharmacology & Therapeutics. 101(4):453-457 | doi: 10.1002/cpt.569 March 2017
Bioprinted three dimensional human tissues for toxicology and disease modeling
Drug Discovery Today Technhology. 23:37-44 | doi: 10.1016/j.ddtec.2017.03.001 March 2017
3D proximal tubule tissues recapitulate key aspects of renal physiology to enable nephrotoxicity testing
Frontiers in Physiology. 8:123 | doi: 10.3389/fphys.2017.00123 September 2016
Modeling compound-induced fibrogenesis in vitro using three-dimensional bioprinted human liver tissues
Toxicological Sciences. 154(2):354-367 | doi:10.1093/toxsci/kfw169 July 2017
Bioprinted 3D primary liver tissues allow assessment of organ-level response to clinical drug induced toxicity in vitro
PLoS One. 11(7):e0158674 | doi: 10.1371/journal.pone.0158674 October 2015
August 2012
3D cell bioprinting for regenerative medicine research and therapies
Gene Therapy & Regulation. 7(1):1230004 | doi: 10.1142/S1568558611000301 June 2012
Toward engineering functional organ modules by additive manufacturing
Biofabrication. 4(2):022001 | doi: 10.1088/1758-5082/4/2/022001 June 2010
Tissue engineering by self-assembly and bio-printing of living cells
Biofabrication. 2(2):022001 | doi: 10.1088/1758-5082/2/2/022001 October 2009
Scaffold-free vascular tissue engineering using bioprinting
Biomaterials. 30(30):5910-5917 | doi: 10.1016/j.biomaterials.2009.06.034 March 2008
Tissue engineering by self-assembly of cells printed into topologically defined structures
Tissue Engineering. 14(3):413-421 | doi: 10.1089/tea.2007.0173 April 2007
Bioprinting living structures
Journal of Materials Chemistry. 17:2054-2060 | doi: 10.1039/B617903G January 2006
Before programs: The physical origination of multicellular forms
International Journal of Developmental Biology. 50(2-3):289-299 | doi: 10.1387/ijdb.052049sn October 2005
Role of physical mechanisms in biological self organization
Physical Review Letters. 95(17):178104 | doi: 10.1103/PhysRevLett.95.178104 May 2004
CompuCell, a multi-model framework for simulation of morphogenesis
Bioinformatics. 20(7):1129-1137 | doi: 10.1093/bioinformatics/bth050 March 2004
Engineering biological structures of prescribed shape using self-assembling multicellular systems
PNAS. 101(9):2864-2869 | doi: 10.1073/pnas.0400164101 December 2003
Organ printing: self-assembling cell aggregates as a "bioink"
Science & Medicine. 9(2):69-71 | doi: 10.1152/ajpcell.00394.2001 March 2002
